 Kevin Rothchild
Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 8 | 2023 | 197 | 1.050 |
Why?
| | Gastric Bypass | 5 | 2023 | 92 | 0.780 |
Why?
| | Bariatric Surgery | 3 | 2022 | 161 | 0.350 |
Why?
| | Weight Loss | 5 | 2023 | 642 | 0.270 |
Why?
| | Laparoscopy | 3 | 2015 | 388 | 0.200 |
Why?
| | Insurance | 1 | 2021 | 11 | 0.190 |
Why?
| | Gastrectomy | 2 | 2022 | 82 | 0.160 |
Why?
| | Neoplasms, Experimental | 3 | 2004 | 152 | 0.140 |
Why?
| | Cefoxitin | 1 | 2016 | 8 | 0.140 |
Why?
| | Gastric Acid | 1 | 2014 | 13 | 0.120 |
Why?
| | Body Mass Index | 3 | 2022 | 1958 | 0.120 |
Why?
| | Mental Disorders | 1 | 2022 | 889 | 0.120 |
Why?
| | Surgical Wound Infection | 1 | 2016 | 248 | 0.110 |
Why?
| | Proton Pump Inhibitors | 1 | 2014 | 96 | 0.110 |
Why?
| | Insurance Coverage | 1 | 2015 | 201 | 0.110 |
Why?
| | Postoperative Care | 1 | 2014 | 219 | 0.110 |
Why?
| | Gastroesophageal Reflux | 1 | 2014 | 234 | 0.100 |
Why?
| | Retrospective Studies | 7 | 2023 | 12515 | 0.090 |
Why?
| | Medicaid | 1 | 2015 | 407 | 0.090 |
Why?
| | Length of Stay | 1 | 2015 | 949 | 0.090 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2001 | 139 | 0.090 |
Why?
| | Patient Readmission | 1 | 2015 | 608 | 0.080 |
Why?
| | T-Lymphocyte Subsets | 2 | 2004 | 384 | 0.060 |
Why?
| | Complementarity Determining Regions | 1 | 2004 | 44 | 0.060 |
Why?
| | Antibodies, Monoclonal | 2 | 2001 | 1270 | 0.060 |
Why?
| | Obesity | 1 | 2016 | 2513 | 0.060 |
Why?
| | Quality of Life | 1 | 2015 | 2358 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2023 | 9089 | 0.050 |
Why?
| | Immunotherapy, Adoptive | 1 | 2004 | 184 | 0.050 |
Why?
| | Suture Techniques | 1 | 2023 | 115 | 0.050 |
Why?
| | Demography | 1 | 2022 | 262 | 0.050 |
Why?
| | Receptors, Nerve Growth Factor | 1 | 2001 | 15 | 0.050 |
Why?
| | Emergency Service, Hospital | 2 | 2022 | 1812 | 0.050 |
Why?
| | Reoperation | 1 | 2023 | 514 | 0.050 |
Why?
| | Endoscopy | 1 | 2023 | 248 | 0.050 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2000 | 27 | 0.050 |
Why?
| | Weight Gain | 1 | 2023 | 452 | 0.040 |
Why?
| | Adult | 5 | 2021 | 30548 | 0.040 |
Why?
| | Humans | 8 | 2023 | 114757 | 0.040 |
Why?
| | Female | 8 | 2021 | 59507 | 0.030 |
Why?
| | T-Lymphocytes | 2 | 2001 | 1745 | 0.030 |
Why?
| | Monte Carlo Method | 1 | 2016 | 137 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2016 | 285 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2015 | 4420 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 2016 | 96 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 301 | 0.030 |
Why?
| | Gastric Acidity Determination | 1 | 2014 | 7 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2312 | 0.030 |
Why?
| | Hospitals, University | 1 | 2015 | 171 | 0.030 |
Why?
| | Time Factors | 2 | 2015 | 6124 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 126 | 0.030 |
Why?
| | Body Weight | 1 | 2016 | 869 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1846 | 0.030 |
Why?
| | Middle Aged | 3 | 2016 | 26757 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2021 | 2127 | 0.020 |
Why?
| | Lymph Nodes | 2 | 2004 | 423 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 1128 | 0.020 |
Why?
| | Male | 4 | 2016 | 55579 | 0.020 |
Why?
| | Patient Discharge | 1 | 2015 | 769 | 0.020 |
Why?
| | United States | 2 | 2015 | 12176 | 0.020 |
Why?
| | Cohort Studies | 1 | 2015 | 4901 | 0.020 |
Why?
| | L-Selectin | 1 | 2004 | 25 | 0.010 |
Why?
| | Clone Cells | 1 | 2004 | 248 | 0.010 |
Why?
| | Brain Neoplasms | 2 | 2001 | 984 | 0.010 |
Why?
| | Mice | 3 | 2004 | 14916 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2004 | 1151 | 0.010 |
Why?
| | Mice, Inbred C57BL | 2 | 2001 | 4710 | 0.010 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 2001 | 19 | 0.010 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2001 | 18 | 0.010 |
Why?
| | Sarcoma, Experimental | 1 | 2000 | 5 | 0.010 |
Why?
| | Receptors, OX40 | 1 | 2000 | 15 | 0.010 |
Why?
| | Mice, SCID | 1 | 2001 | 320 | 0.010 |
Why?
| | Melanoma, Experimental | 1 | 2000 | 89 | 0.010 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2000 | 114 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 10463 | 0.010 |
Why?
| | Epitopes | 1 | 2001 | 435 | 0.010 |
Why?
| | Antigens, CD | 1 | 2001 | 443 | 0.010 |
Why?
| | Glioma | 1 | 2000 | 294 | 0.010 |
Why?
| | Animals | 3 | 2004 | 31762 | 0.010 |
Why?
| | Phenotype | 1 | 2001 | 2812 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2001 | 2199 | 0.000 |
Why?
|
|
Rothchild's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|